XORTX Therapeutics (XRTX) News
NASDAQ: XRTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
XRTX news summary
We found 1 recent headline mentioning XORTX Therapeutics (XRTX): 1 in the past week and 1 in the past 30 days, most often from GlobeNewswire. XRTX is making an outsized move today, down 23.78% at $1.41, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "XORTX Outlines Anticipated Health Canada Clinical Trial Application for XRx-026 for Gout", was published by GlobeNewswire on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology